Patents by Inventor Peter Gmeiner

Peter Gmeiner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100168125
    Abstract: The present application relates to indolizine-based compounds of the general formula (I) and aza-analogs thereof, which have medical utility, for example as antipsychotics.
    Type: Application
    Filed: March 18, 2008
    Publication date: July 1, 2010
    Inventors: Peter Gmeiner, Harald Huebner, Marika Skultety
  • Publication number: 20090209516
    Abstract: The invention relates to compounds according to general formula (1) and/or their enantiomers, diastereomers, and their pharmaceutically compatible salts, and their use to manufacture a medication as well as medications. The compounds are suited for treatment of diseases connected with misfolded proteins.
    Type: Application
    Filed: August 21, 2008
    Publication date: August 20, 2009
    Inventors: Carsten Korth, Ralf Klingenstein, Stefan Lober, Peter Gmeiner, B. Kieseier, G. Meyer zu Horste, Olaf Stuve
  • Publication number: 20090150705
    Abstract: A method for operating cooperating, differing devices, particularly of a plant, with different controls controlling the control sequences and in particular with different control cycles, is characterized in that the clocks (IPOi) of the different controls (3.1, 3.2, 3.3) are interpolated on a common system clock (tTick) and that the control sequences are synchronized. An apparatus suitable for performing the inventive method correspondingly has at least one common interpolating device (5.3) for the controls (3.1, 3.2, 3.3) for interpolating the cycles (IPOi) of the different controls (3.1, 3.2, 3.3) on a common system clock (tTick) and at least one synchronizing device (5) for synchronizing the control sequences.
    Type: Application
    Filed: December 4, 2004
    Publication date: June 11, 2009
    Inventor: Peter Gmeiner
  • Publication number: 20090124001
    Abstract: The invention relates to compounds according to general formula (1) and/or their enantiomers, diastereomers as well as their pharmaceutically compatible salts, and to the use thereof for producing a medicament suited for treating diseases associated with misfolded proteins.
    Type: Application
    Filed: February 28, 2006
    Publication date: May 14, 2009
    Applicant: HEINRICH-HEINE UNIVERSITÄT DUSSELDORF
    Inventors: Carsten Korth, Ralf Klingenstein, Stefan Lober, Peter Gmeiner
  • Publication number: 20080292051
    Abstract: An imaging device with a radiographic source and with at least one image receiver, with an imaging detector able to be assigned to the image receiver or to each image receiver and with the image receiver or each image receiver including a sensor for registration of the imaging detector, with a signal output of the sensor being connected directly in a circuit to a signal input of the radiographic source.
    Type: Application
    Filed: April 18, 2008
    Publication date: November 27, 2008
    Inventors: Thomas Dippl, Gerhard Friedrich, Ute Friedrich, Peter Gmeiner, Claus-Gunter Schliermann, Elisabeth Friedrich
  • Publication number: 20080194539
    Abstract: The invention relates to annelated phenyl piperazine and phenyl diazepane carboxamides of general formula (I) containing oxygen. The compounds are suitable for medical use.
    Type: Application
    Filed: December 27, 2005
    Publication date: August 14, 2008
    Applicant: Schwarz Pharma AG
    Inventors: Peter Gmeiner, Harald Hubner, Karin Schlotter
  • Publication number: 20080051409
    Abstract: The present invention concerns neuroreceptor-active carboxamide-substituted indolizine derivatives of general formula I wherein X represents a group of general formula X1
    Type: Application
    Filed: July 29, 2005
    Publication date: February 28, 2008
    Inventors: Peter Gmeiner, Harald Hubner, Laura Bettinetti, Karin Schlotter
  • Publication number: 20070299091
    Abstract: The invention relates to azaindole derivatives of general formula (I), wherein X represents a group of general formula (X1). Said compounds have a therapeutic potential in the treatment of diseases that are accompanied by an impaired dopamine metabolism and/or abnormal serotonin-5-HT1a signal transmission.
    Type: Application
    Filed: November 11, 2005
    Publication date: December 27, 2007
    Inventors: Peter Gmeiner, Karin Schlotter, Harald Huber, Dirk Schmidt, Monika Buchholz
  • Patent number: 7292910
    Abstract: A method for machining workpieces by means of a multiaxial manipulator, such as an industrial robot, with a tool moved proportionally by a control unit of the manipulator and which can perform characteristic movements with several degrees of freedom is characterized in that the degrees of freedom of the tool are evaluated together with the degrees of freedom of axes of the manipulator in real time for moving a tool tip (TCP) in accordance with a predetermined, continuous machining path or a portionwise continuous machining geometry (step function) and for determining a movement of the manipulator. The invention also proposes a device suitable for performing the aforementioned method, in which the tool and a tool tip, during workpiece machining, are movement-controllable by the manipulator control unit. In this way it is possible to drastically reduce the overall machining time.
    Type: Grant
    Filed: November 24, 2003
    Date of Patent: November 6, 2007
    Assignee: KUKA Roboter GmbH
    Inventor: Peter Gmeiner
  • Publication number: 20050197343
    Abstract: The invention relates to neuroreceptor active N-[(4-phenyl-1-piperazinyl)alkyl]-substituted heteroarene carboxamide of general formula (I) and to structure analogous 2-ferrocenyl compounds of general formula (II) and the utilization thereof for the treatment of CNS diseases, for example, schizophrenia, different forms of depression, neurodegenerative disorders, sexual dysfunctions, cocaine, alcohol, opiate and nicotine addiction, in addition to glaucoma, cognitive disorders, restless leg syndrome, hyperactivity syndrome (ADHS), hyperprolactinemia, hyperprolactinoma, locomotion disorders associated with Parkinson's disease, treatment of L-DOPA and neuroleptic-induced locomotion disorders, for example, akathisia, rigor, dystonia and dyskinesia, wherein the substituents are defined in the description.
    Type: Application
    Filed: July 2, 2003
    Publication date: September 8, 2005
    Inventors: Peter Gmeiner, Harald Hubner, Karin Schlotter
  • Publication number: 20040111185
    Abstract: A method for machining workpieces by means of a multiaxial manipulator, such as an industrial robot, with a tool moved proportionally by a control unit of the manipulator and which can perform characteristic movements with several degrees of freedom is characterized in that the degrees of freedom of the tool are evaluated together with the degrees of freedom of axes of the manipulator in real time for moving a tool tip (TCP) in accordance with a predetermined, continuous machining path or a portionwise continuous machining geometry (step function) and for determining a movement of the manipulator. The invention also proposes a device suitable for performing the aforementioned method, in which the tool and a tool tip, during workpiece machining, are movement-controllable by the manipulator control unit. In this way it is possible to drastically reduce the overall machining time.
    Type: Application
    Filed: November 24, 2003
    Publication date: June 10, 2004
    Inventor: Peter Gmeiner
  • Patent number: 4859664
    Abstract: New 2,3,4,5,6,7-hexahydro-2,7-methano-1,5-benzoxazonine and -1,4-benzoxazonine compounds of the formula ##STR1## have useful pharmaceutical properites. They are prepared from ketones of the formula ##STR2## via a lactone intermediate. In the formula, the various R substitutes are generally hydrogen or alkyl, with R.sup.4 also being halogen or alkoxy and R.sup.3 R.sup.3' also being phenyl. R.sup.1 may be joined with R.sup.5 /R.sup.5' in a 5- to 7-membered ring possibly interrupted by O, S, SO.sub.2 or amino. One of X and Y is CH.sub.2 ; the other is amino. The starting ketones also have pharmaceutical properties. The lactone intermediates are new compounds.
    Type: Grant
    Filed: September 4, 1987
    Date of Patent: August 22, 1989
    Assignee: Madaus GmbH & Company
    Inventors: Friedrich Eiden, Peter Gmeiner, Jurgen Schunemann